# Advanced Micro Devices (AMD) — InvestMoat Analysis

_Last analyzed: September 23, 2026_
_Asset class: equity · Canonical page: https://investmoat.com/stocks/amd_

## Scores

| Dimension | Score (0–100) |
| --- | --- |
| Moat durability | 47 |
| Growth trajectory | 88 |
| Valuation | 61 |
| **Composite** | **62** |

Scores are computed deterministically from this asset’s data by the InvestMoat formula (see https://investmoat.com/llms.txt for methodology). Scores are not directly comparable across asset classes.

## Key stats

- **Ticker:** AMD
- **Market Cap:** ~$1.0T

## Moat

September 2026 review: Q2 printed and Helios launched, but the moat did not deepen a grade. AMD's edge is still execution, not structural lock-in — the primary x86 alternative (EPYC Turin/Venice share gains) and a credible #2 AI accelerator, with OpenAI (6 GW), Meta (6 GW), Anthropic (up to 2 GW), and Azure Helios commitments deepening second-source embedding. ROCm.ai and 3 million day-zero models are a capability print, not a CUDA-class developer flywheel. The only status change is systemOfRecord, corrected from weakened to na — the old note treated 'not the default GPU' as a system of record, which the pillar forbids. The score moves only because that weak box drops out, not because of a new advantage.

### The Chiplet Edge

AMD's advantage lies in **Architectural Efficiency**:

- **Chiplet Innovation:** AMD led the transition to chiplets, allowing for higher yields and more flexible SKU creation compared to monolithic designs. Helios extends that into a rack — 72× MI455X, Venice CPUs, and Pensando networking as one scale-up domain — but the architectural lead is still a cost/performance edge, not a lock-in.
- **x86 Market Share Capture:** Q2 was the fifth consecutive record server-CPU quarter: cloud and enterprise EPYC each grew more than 70% year over year, and Venice is in production with every major OEM. That is share capture against Intel, not a new switching cost.
- **Open Ecosystem:** ROCm.ai and a claimed 3 million models running out of the box make the port easier. OpenAI, Anthropic, Meta, and Azure are co-optimising on Instinct. The stack is a viable second source, not a CUDA replacement — hyperscalers still buy it for vendor flexibility.

**Moat verdict:** AMD is a net AI beneficiary in demand and a laggard in AI-resilient structural moats versus NVIDIA. The Q2 print ($11.5B, Data Center +107%) and the Helios launch with Anthropic 2 GW plus Azure do not change that: they deepen transaction embedding that was already intact, and they leave learned interfaces, bundling, and network effects weakened against CUDA. Proprietary CDNA/ROCm IP and scarce chip talent are the durable sources; the software flywheel is still NVIDIA's. Execution is world-class. The upside is still a CUDA challenger, not a CUDA replacer — and the ~$1T cap prices the challenger path as the base case.

### Top competitors

- **[NVIDIA (NVDA)](https://investmoat.com/stocks/nvda):** Data-center GPUs and the CUDA software stack AMD's Instinct line must displace.
- **Intel (INTC):** x86 CPUs in PCs and servers — the EPYC and Ryzen share battle.
- **[Broadcom (AVGO)](https://investmoat.com/stocks/avgo):** Custom AI accelerators (XPUs) hyperscalers build instead of buying merchant GPUs.

## Growth

Q2 2026 (quarter ended June 27, reported August 4) printed revenue $11.536B, +50% from $7.685B a year ago and +13% from Q1's $10.253B, beating the $11.2B guide. Data Center was $6.718B, +107% YoY and 58% of sales (from 42% a year ago). Non-GAAP gross margin 56%, operating margin 27%, diluted EPS $1.66; GAAP EPS $1.38. Q3 is guided at $13.0B ±$300M (~+41% YoY, ~+13% QoQ) with non-GAAP GM ~56%. Helios is in production — first shipments late Q3, a step-up in Q4, then through 2027. Management now puts the data-center AI accelerator TAM at more than 45% annually to ~$1.4T by 2030 and the server-CPU TAM at more than 50% to ~$220B, and says company revenue grows above a >40% high-performance/AI compute market. They expect to significantly exceed the $20 Financial Analyst Day EPS target inside the strategic window. H1 free cash flow was $4.124B; cash and short-term investments $13.111B.

- **Revenue CAGR estimate:** 32–42%
- **Primary type:** both
- **Margin trend:** expanding
- **Key risk (high):** If NVIDIA's Rubin Ultra widens the performance gap on flagship training workloads through 2027 and ROCm fails to convert the 3-million-model / ROCm.ai print into production CUDA-equivalent share, AMD's AI GPU share stalls below 15% of TAM and the 32–42% CAGR collapses toward 15–20% — invalidating the OpenAI/Anthropic/Azure upgrade cycle priced into the ~$1T re-rating. This is a cyclical hardware print: the +50% sits near the top of a hyperscaler capex cycle, and a digestion year would cut the second-source vendor's orders before the incumbent's.
- **Drivers:**
  - Data Center / Instinct GPUs — Q2 2026 Data Center $6.718B, +107% YoY, 58% of sales; Instinct more than doubled; Helios in production, first shipments late Q3 (accelerating)
  - EPYC Server CPUs — Fifth consecutive record server-CPU quarter; cloud and enterprise each +70% YoY; server revenue guided +80% in 2H 2026 and +70% for FY2027 (accelerating)
  - Client / Ryzen — Q2 client $3.062B, +23% YoY; H2 PC market guided softer on memory/component costs — hold stable, do not mark up the print (stable)
- **Score derivation:** Base 91.8 (32–42% CAGR, midpoint 37%, baseFromCagr) + 2.7 trajectory (2 of 3 drivers accelerating) + 4 expanding margins (non-GAAP GM 56%; op margin 27%, +2 ppts QoQ) − 10 high keyRisk (NVIDIA Rubin Ultra still the unmaterialised overhang; Helios just entering production) = 88. Do not bump because they beat. primaryType does not score.

## Valuation

At ~$624 (fresh ATH, ~$1.0T), AMD trades above the revised base ($570). The Q2 print and Helios/Anthropic/Azure commitments re-rated FY2027 consensus EPS from ~$13 to ~$15.5, and the ~$620–628 average analyst target sits on spot — but that is per current share. OpenAI holds a warrant for up to 160M AMD shares at $0.01 (~9.6% of the ~1.66B diluted count), vesting as its GPU purchases scale from 1 GW to 6 GW; the share-price hurdles escalate to $600 for the final tranche, which spot has already cleared. The base case assumes OpenAI deploys, so it assumes the warrant vests: ~$15.5 becomes ~$14.1 per fully diluted share. The AI thesis is priced as the base case, not as optionality.

| Multiple | Value | Note |
| --- | --- | --- |
| Trailing P/E (GAAP) | ~160× | GAAP TTM EPS ~$3.89 |
| Forward P/E (NTM) | ~54× | consensus NTM EPS ~$11.5 |
| PEG Ratio | ~1.5× | fwd P/E ÷ ~37% EPS CAGR |
| Price / Sales (NTM) | ~15× | ~$68B NTM revenue |
| Price / FCF | ~125× | H1 FCF $4.1B annualised |
| OpenAI warrant | ~9.6% | 160M shares at $0.01 vs ~1.66B diluted; vests with 1–6 GW of purchases |

The ~54× forward P/E is expensive versus the semis peer group and the broad market (~21×), but it is no longer the July 65× on an $8.50 NTM that assumed a flawless MI450 ramp still ahead. A PEG of ~1.5× is premium-but-defensible only if the 32–42% CAGR holds, and every multiple here is on the current share count — full warrant vesting lifts each by ~10%. The gap between ~160× trailing GAAP and ~54× forward still prices a steep 2026–27 earnings ramp — now consensus, not a beat. _(as of September 2026)_

## Price scenarios

### Bear — $280

AI capex digestion in 2027, NVIDIA reasserts dominance with Rubin Ultra, and the OpenAI/Anthropic/Azure deployments slip. A cyclical bear cuts earnings and the multiple together: FY2027 EPS stalls near ~$11 instead of ~$15.5, at ~25×. Slipped deployments also leave most of the OpenAI warrant unvested, so dilution is small here.

- Hyperscaler AI capex growth decelerates from 40%+ to mid-teens as training-cluster overbuild concerns surface, and the second-source vendor's orders are cut first
- Rubin Ultra performance leadership widens vs. MI450/Helios, capping AMD's share of new AI GPU spend at <15%
- Intel 18A plus a softer H2 PC market slow EPYC and Ryzen compounding together

### Base — $570

Helios ramps from late-Q3 shipments through 2027, the OpenAI, Anthropic 2 GW, Meta, and Azure deployments land as guided, and Data Center more than doubles in 2027 — ~40× FY2027 EPS of ~$14.1 per fully diluted share (consensus ~$15.5 with the OpenAI warrant's 160M shares issued, since the base case is the one where OpenAI's purchases vest it).

- Helios volume in Q4 2026 and through 2027 converts the named GW-scale commitments into Data Center growth that more than doubles the segment
- EPYC server revenue grows more than 70% in FY2027 off the raised 2026 base, tracking the $220B 2030 server-CPU TAM
- Non-GAAP operating margin holds in the high-20s as AI mix and ROCm adoption offset Helios ramp yields

### Bull — $875

AMD becomes a credible second AI standard, capturing 25%+ of AI GPU spend as ROCm reaches functional parity with CUDA for inference and key training workloads — FY2027 EPS beats toward the $20 FAD target (~$18.2 per fully diluted share once OpenAI's 6 GW vests the full warrant) at a sustained ~48× multiple.

- MI500 (2027) achieves performance parity with NVIDIA on flagship training workloads and the annual rack-scale cadence holds
- Anthropic's 2 GW plus OpenAI/Meta scale toward a second multi-GW hyperscaler, and ROCm.ai converts the 3-million-model print into production share
- Company revenue stays above the >40% TAM print long enough for FY2027 EPS to clear $20 inside the strategic window

---

InvestMoat is a research and education framework. Nothing here is financial advice. Past performance does not guarantee future results.